Literature DB >> 24300918

New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase.

Mariana Ferrer-Casal1, Catherine Li2, Melina Galizzi2, Carlos A Stortz3, Sergio H Szajnman1, Roberto Docampo2, Silvia N J Moreno2, Juan B Rodriguez4.   

Abstract

As part of our project pointed at the search of new antiparasitic agents against American trypanosomiasis (Chagas disease) and toxoplasmosis a series of 2-alkylaminoethyl-1-hydroxy-1,1-bisphosphonic acids has been designed, synthesized and biologically evaluated against the etiologic agents of these parasitic diseases, Trypanosoma cruzi and Toxoplasma gondii, respectively, and also towards their target enzymes, T. cruzi and T. gondii farnesyl pyrophosphate synthase (FPPS), respectively. Surprisingly, while most pharmacologically active bisphosphonates have a hydroxyl group at the C-1 position, the additional presence of an amino group at C-3 resulted in decreased activity towards either T. cruzi cells or TcFPPS. Density functional theory calculations justify this unexpected behavior. Although these compounds were devoid of activity against T. cruzi cells and TcFPPS, they were efficient growth inhibitors of tachyzoites of T. gondii. This activity was associated with a potent inhibition of the enzymatic activity of TgFPPS. Compound 28 arises as a main example of this family of compounds exhibiting an ED₅₀ value of 4.7 μM against tachyzoites of T. gondii and an IC₅₀ of 0.051 μM against TgFPPS.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiparasitic agents; Bisphosphonates; Farnesyl pyrophosphate synthase; Toxoplasma gondii; Trypanosoma cruzi

Mesh:

Substances:

Year:  2013        PMID: 24300918      PMCID: PMC3902031          DOI: 10.1016/j.bmc.2013.11.010

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  51 in total

1.  Enzymatic Aspects of Isoprenoid Chain Elongation.

Authors:  Kyozo Ogura; Tanetoshi Koyama
Journal:  Chem Rev       Date:  1998-06-18       Impact factor: 60.622

Review 2.  New antibacterials for the treatment of toxoplasmosis; a patent review.

Authors:  Juan Bautista Rodriguez; Sergio Hernán Szajnman
Journal:  Expert Opin Ther Pat       Date:  2012-03-10       Impact factor: 6.674

3.  The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates.

Authors:  Yan Ling; Zhu-Hong Li; Kildare Miranda; Eric Oldfield; Silvia N J Moreno
Journal:  J Biol Chem       Date:  2007-08-27       Impact factor: 5.157

4.  Genetic evidence that an endosymbiont-derived endoplasmic reticulum-associated protein degradation (ERAD) system functions in import of apicoplast proteins.

Authors:  Swati Agrawal; Giel G van Dooren; Wandy L Beatty; Boris Striepen
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

5.  Binding of nitrogen-containing bisphosphonates (N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimer.

Authors:  Chuan-Hsiang Huang; Sandra B Gabelli; Eric Oldfield; L Mario Amzel
Journal:  Proteins       Date:  2010-03

6.  Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi.

Authors:  G M Cinque; S H Szajnman; L Zhong; R Docampo; A J Schvartzapel; J B Rodriguez; E G Gros
Journal:  J Med Chem       Date:  1998-04-23       Impact factor: 7.446

7.  Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.

Authors:  M B Martin; J S Grimley; J C Lewis; H T Heath; B N Bailey; H Kendrick; V Yardley; A Caldera; R Lira; J A Urbina; S N Moreno; R Docampo; S L Croft; E Oldfield
Journal:  J Med Chem       Date:  2001-03-15       Impact factor: 7.446

8.  Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity.

Authors:  Joo Hwan No; Fernando de Macedo Dossin; Yonghui Zhang; Yi-Liang Liu; Wei Zhu; Xinxin Feng; Jinyoung Anny Yoo; Eunhae Lee; Ke Wang; Raymond Hui; Lucio H Freitas-Junior; Eric Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

9.  Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group.

Authors:  E Van Beek; C Löwik; I Que; S Papapoulos
Journal:  J Bone Miner Res       Date:  1996-10       Impact factor: 6.741

10.  Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthases.

Authors:  Rong Cao; Cammy K-M Chen; Rey-Ting Guo; Andrew H-J Wang; Eric Oldfield
Journal:  Proteins       Date:  2008-11-01
View more
  6 in total

1.  Synthesis and biological evaluation of 1-alkylaminomethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii.

Authors:  Tamila Galaka; Bruno N Falcone; Catherine Li; Sergio H Szajnman; Silvia N J Moreno; Roberto Docampo; Juan B Rodriguez
Journal:  Bioorg Med Chem       Date:  2019-07-04       Impact factor: 3.641

2.  Pharmacophore modeling, docking and molecular dynamics to identify Leishmania major farnesyl pyrophosphate synthase inhibitors.

Authors:  Larissa de Mattos Oliveira; Janay Stefany Carneiro Araújo; David Bacelar Costa Junior; Isis Bugia Santana; Angelo Amâncio Duarte; Franco Henrique Andrade Leite; Raquel Guimarães Benevides; Manoelito Coelho Dos Santos Junior
Journal:  J Mol Model       Date:  2018-10-16       Impact factor: 1.810

Review 3.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

4.  Direct N-alkylation of unprotected amino acids with alcohols.

Authors:  Tao Yan; Ben L Feringa; Katalin Barta
Journal:  Sci Adv       Date:  2017-12-08       Impact factor: 14.136

5.  Antiparasitic Activity of Sulfur- and Fluorine-Containing Bisphosphonates against Trypanosomatids and Apicomplexan Parasites.

Authors:  Tamila Galaka; Mariana Ferrer Casal; Melissa Storey; Catherine Li; María N Chao; Sergio H Szajnman; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  Molecules       Date:  2017-01-04       Impact factor: 4.411

Review 6.  Advances in preclinical approaches to Chagas disease drug discovery.

Authors:  Fernando Villalta; Girish Rachakonda
Journal:  Expert Opin Drug Discov       Date:  2019-08-14       Impact factor: 6.098

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.